A detailed history of Allianz Asset Management Gmb H transactions in Glaukos Corp stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 62,686 shares of GKOS stock, worth $9.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
62,686
Previous 62,281 0.65%
Holding current value
$9.17 Million
Previous $7.37 Million 10.8%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$113.62 - $135.39 $46,016 - $54,832
405 Added 0.65%
62,686 $8.17 Million
Q2 2024

Aug 13, 2024

BUY
$89.48 - $118.35 $1.16 Million - $1.53 Million
12,917 Added 26.17%
62,281 $7.37 Million
Q1 2024

May 13, 2024

SELL
$76.4 - $96.33 $510,275 - $643,388
-6,679 Reduced 11.92%
49,364 $4.65 Million
Q4 2023

Feb 12, 2024

BUY
$59.53 - $85.11 $65,483 - $93,621
1,100 Added 2.0%
56,043 $4.45 Million
Q3 2023

Nov 13, 2023

SELL
$69.23 - $79.09 $692,092 - $790,662
-9,997 Reduced 15.39%
54,943 $4.13 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $233,288 - $365,592
5,134 Added 8.58%
64,940 $4.62 Million
Q1 2023

May 11, 2023

SELL
$43.88 - $52.48 $2,413 - $2,886
-55 Reduced 0.09%
59,806 $3 Million
Q4 2022

Feb 13, 2023

SELL
$40.82 - $57.75 $38,370 - $54,285
-940 Reduced 1.55%
59,861 $2.61 Million
Q3 2022

Nov 08, 2022

BUY
$46.84 - $58.49 $2.85 Million - $3.56 Million
60,801 New
60,801 $3.24 Million
Q1 2019

May 13, 2019

SELL
$50.75 - $80.54 $998,049 - $1.58 Million
-19,666 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$52.18 - $67.93 $565,318 - $735,953
-10,834 Reduced 35.52%
19,666 $1.11 Million
Q3 2018

Nov 13, 2018

BUY
$38.13 - $68.37 $1.16 Million - $2.09 Million
30,500 New
30,500 $1.98 Million
Q3 2017

Nov 13, 2017

SELL
$31.26 - $42.03 $188,747 - $253,777
-6,038 Closed
0 $0
Q1 2017

Apr 17, 2019

BUY
N/A
6,038
6,038 $310,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.97B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.